Remission of type 2 diabetes in patients undergoing biliointestinal bypass for morbid obesity: a new surgical treatment

BIBP had a favorable risk-benefit relationship and positive metabolic effects in the short term. How BIBP achieves optimal glycemic control and whether it improves β-cell function and/or insulin sensitivity require further study.